Literature DB >> 9820146

The neutralizing antibody response against a conserved region of human immunodeficiency virus type 1 gp41 (amino acid residues 731-752) is uniquely directed against a conformational epitope.

E Buratti1, L McLain, S Tisminetzky, S M Cleveland, N J Dimmock, F E Baralle.   

Abstract

Amino acids 731-752 (731PRGPDRPEGIEEEGGERDRDRS752) of the transmembrane glycoprotein gp41 of human immunodeficiency virus type 1 (HIV-1) are conserved in most virus isolates and are controversially reported to be implicated in virus neutralization. The humoral response in infected patients against this region is poor and humans immunized with gp160 show high levels of antibodies against the peptide but poor neutralization titres. Nonetheless, several groups have succeeded in obtaining neutralizing antibodies against this sequence using different antigen-presenting systems. In order to identify the sequence(s) against which the neutralizing response was generated, we used the flock house virus (FHV) antigen-presenting system to analyse neutralizing antisera from mice immunized with a cowpea mosaic virus (CPMV) chimera expressing the 731-752 sequence. Data show that the neutralizing response is uniquely directed against a conformational epitope mapping to the ERDRD portion of this sequence, although the major antibody response, which is non-linear, and is not neutralizing, is against an IEEE epitope. These results provide an explanation for the controversy regarding the immunogenicity of this region of gp41 and suggest that this conformational epitope, in the absence of the non-neutralizing epitope, should be considered for a subunit vaccine. In addition, this study highlights the usefulness of antigen-presenting systems that preserve epitope conformation in the investigation of immune responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9820146     DOI: 10.1099/0022-1317-79-11-2709

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

Review 1.  The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design.

Authors:  Marinieve Montero; Nienke E van Houten; Xin Wang; Jamie K Scott
Journal:  Microbiol Mol Biol Rev       Date:  2008-03       Impact factor: 11.056

2.  Induction of HIV-blocking anti-CCR5 IgA in Peyers's patches without histopathological alterations.

Authors:  Claudia Pastori; Lorenzo Diomede; Assunta Venuti; Gregory Fisher; Jonathan Jarvik; Morgane Bomsel; Francesca Sanvito; Lucia Lopalco
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

3.  Blockage of CD59 Function Restores Activities of Neutralizing and Nonneutralizing Antibodies in Triggering Antibody-Dependent Complement-Mediated Lysis of HIV-1 Virions and Provirus-Activated Latently Infected Cells.

Authors:  Kai Yang; Jie Lan; Nicole Shepherd; Ningjie Hu; Yanyan Xing; Daniel Byrd; Tohti Amet; Corlin Jewell; Samir Gupta; Carole Kounga; Jimin Gao; Qigui Yu
Journal:  J Virol       Date:  2015-07-01       Impact factor: 5.103

4.  Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy.

Authors:  C Barassi; E Soprana; C Pastori; R Longhi; E Buratti; F Lillo; C Marenzi; A Lazzarin; A G Siccardi; L Lopalco
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 5.  The frantic play of the concealed HIV envelope cytoplasmic tail.

Authors:  Eveline Santos da Silva; Martin Mulinge; Danielle Perez Bercoff
Journal:  Retrovirology       Date:  2013-05-24       Impact factor: 4.602

6.  CCR5: From Natural Resistance to a New Anti-HIV Strategy.

Authors:  Lucia Lopalco
Journal:  Viruses       Date:  2010-02-05       Impact factor: 5.818

Review 7.  Natural anti-CCR5 antibodies in HIV-infection and -exposure.

Authors:  Lucia Lopalco
Journal:  J Transl Med       Date:  2011-01-27       Impact factor: 5.531

8.  The C-terminal tail of the gp41 transmembrane envelope glycoprotein of HIV-1 clades A, B, C, and D may exist in two conformations: an analysis of sequence, structure, and function.

Authors:  Mark J Hollier; Nigel J Dimmock
Journal:  Virology       Date:  2005-07-05       Impact factor: 3.616

Review 9.  C-terminal tail of human immunodeficiency virus gp41: functionally rich and structurally enigmatic.

Authors:  Jonathan D Steckbeck; Anne-Sophie Kuhlmann; Ronald C Montelaro
Journal:  J Gen Virol       Date:  2012-10-17       Impact factor: 3.891

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.